ERBB2 and breast carcinoma: Additionally, hypoxia-induced translocation of caveolin from vesicles to plasma membranes has been proposed as a possible mechanism for the reduced internalization of trastuzumab in the hypoxic microenvironment of HER2-positive breast cancer (173).